Comment from American Psychiatric Association

Summary: The American Psychiatric Association (APA) supports the FDA's draft guidance, arguing that flavored electronic nicotine delivery systems (ENDS) pose a significant risk to youth and individuals with mental illness. They advocate for a rigorous premarket review process that requires manufacturers to prove that marketing these products does not harm public health.